Biotech / MedTech
India’s Loopworm raises $3.4M seed round co-led by Omnivore and WaterBridge
India's insect biotech startup Loopworm announced Wednesday that it has raised a $3.4 million seed round co-led by Omnivore and WaterBridge Ventures. The round also saw participation from Titan Capital and leading angel investors including Nadir Godrej (Godrej Agrovet), Sanjiv Rangrass (ex-ITC), and Akshay Singhal (Log9 Materials).
Cordlife partners AMILI to launch gut microbiome banking service in Southeast Asia
Cordlife Group Limited (Cordlife), a Singapore Exchange mainboard listed consumer healthcare company, and AMILI Pte. Ltd. (AMILI), a Singapore-based microbiome firm, announced Tuesday a strategic partnership to provide the first-ever gut microbiome banking service in Singapore and the region.
Singapore’s AMILI raises $10.5M Series A round led by Vulcan Capital
AMILI, a Singapore-based precision gut microbiome company, said Wednesday it has raised$10.5 million in Series A funding to accelerate its business expansion in Southeast Asia and Greater Asia. The round was led by Vulcan Capital, the investment arm of the late Microsoft Corp co-founder Paul Allen that invests in category-leading technology, internet, and…
Amgen and NSG Biolabs announce golden ticket to boost Singapore’s Biotech Ecosystem
As part of the sponsorship, Amgen will support one "Golden Ticket" award each year for three years, providing winners with one year of free residency in NSG Biolabs’ fully equipped turnkey BSL-2 laboratory as well as additional facility benefits and connections to Amgen's scientific and business leaders.
Singapore biotech firm Nalagenetics raises $12.6M Series A funding co-led by Intudo Ventures and Vulcan Capital
Nalagenetics announced Friday the closing of a $12.6 million Series A round of financing co-led by Intudo Ventures and Vulcan Capital. The round also saw participation from strategic investors, including Singapore-based Diagnostics Development Hub (DxD Hub) through the Agency for Science, Technology and Research’s (A*STAR) A*ccelerate Technologies Pte Ltd,…
Malaysian biotechnology firm GK Aqua seeks to raise $478,000 to $1.91M via ECF Platform pitchIN
GK Aqua Sdn Bhd, a Malaysian Biotechnology company is looking to raise a minimum of MYR2 million ($478,000) for 4.26 percent equity with a maximum target of MYR8 million ($1.91 million) for 15.09 percent equity via the Malaysian equity crowdfunding platform pitchIN.
Israel’s MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
MeMed announced Monday a $93 million private financing round, bringing total funding in the company to over $200 million, including support from the U.S. Department of Defense and EU Commission. The funds will be used to scale up manufacturing, accelerate commercialization and expand MeMed’s pioneering host immune response product portfolio, The latest…
Hong Kong unicorn Prenetics to tap vast opportunities in Southeast Asia amid global expansion
Prenetics, which is expected to go public on the Nasdaq in the first quarter of next year, is also actively looking for local partners in Southeast Asia.
Singapore biotech startup RWDC Industries raises $95.1M in Series B2 funding co-led by Vickers Venture Partners and Temasek
RWDC Industries Limited announced the closing of a $95.1 million Series B2 funding round co-led by Singapore venture capital firm Vickers Venture Partners and Singapore state investor Temasek. The funding will support the group’s expansion and boost its production of biodegradable biopolymer material that will help the group speed adoption of sustainable…
